Latest news

Today, 5:38 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30)

ADMA

1 minute read

Eledon Pharmaceuticals Q2 EPS $(0.50) Beats $(0.57) Estimate

By Benzinga Newsdesk

Today, 5:38 PM

Eledon Pharmaceuticals (NASDAQ:ELDN) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.57) by 12.28 percent. This is a 233.33 percent decrease over losses of $(0.15) per

ELDN

5 minute read

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

Today, 5:38 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)

15 minute read

Earnings Scheduled For August 12, 2021

Today, 5:38 PM

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.

AACG

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

Today, 5:38 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

9 minute read

Stocks That Hit 52-Week Lows On Friday

Today, 5:38 PM

Before 10 a.m. ET Friday, 117 stocks made new 52-week lows.

20 minute read

Stocks That Hit 52-Week Lows On Monday

Today, 5:38 PM

Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows.

AAU

14 minute read

Uncategorized

Earnings Scheduled For May 13, 2021

Today, 5:38 PM

Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.

AACG

6 minute read

Uncategorized

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

Today, 5:38 PM

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.